178 related articles for article (PubMed ID: 25900896)
1. Gastrointestinal stromal tumors: treatment patterns of a population-based sample.
Harlan LC; Eisenstein J; Russell MC; Stevens JL; Cardona K
J Surg Oncol; 2015 May; 111(6):702-7. PubMed ID: 25900896
[TBL] [Abstract][Full Text] [Related]
2. Elderly patients with gastrointestinal stromal tumour (GIST) receive less treatment irrespective of performance score or comorbidity - A retrospective multicentre study in a large cohort of GIST patients.
Farag S; van Coevorden F; Sneekes E; Grunhagen DJ; Reyners AKL; Boonstra PA; van der Graaf WT; Gelderblom HJ; Steeghs N
Eur J Cancer; 2017 Nov; 86():318-325. PubMed ID: 29073582
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal stromal tumors (GISTs) at uncommon locations: a large population based analysis.
Kukar M; Kapil A; Papenfuss W; Groman A; Grobmyer SR; Hochwald SN
J Surg Oncol; 2015 May; 111(6):696-701. PubMed ID: 25560251
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal stromal tumor--background, pathology, treatment.
Eisenberg BL; Pipas JM
Hematol Oncol Clin North Am; 2012 Dec; 26(6):1239-59. PubMed ID: 23116579
[TBL] [Abstract][Full Text] [Related]
5. Surgical and medical management of small bowel gastrointestinal stromal tumors: A report of the Dutch GIST registry.
Boonstra PA; Steeghs N; Farag S; van Coevorden F; Gelderblom H; Grunhagen DJ; Desar IME; van der Graaf WTA; Bonenkamp JJ; Reyners AKL; van Etten B
Eur J Surg Oncol; 2019 Mar; 45(3):410-415. PubMed ID: 30416078
[TBL] [Abstract][Full Text] [Related]
6. New fronts in the adjuvant treatment of GIST.
Reichardt P; Joensuu H; Blay JY
Cancer Chemother Pharmacol; 2013 Oct; 72(4):715-23. PubMed ID: 23934322
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal stromal tumors (GIST) related emergencies.
Sorour MA; Kassem MI; Ghazal Ael-H; El-Riwini MT; Abu Nasr A
Int J Surg; 2014; 12(4):269-80. PubMed ID: 24530605
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal stromal tumors: risk assessment and adjuvant therapy.
Joensuu H
Hematol Oncol Clin North Am; 2013 Oct; 27(5):889-904. PubMed ID: 24093166
[TBL] [Abstract][Full Text] [Related]
9. Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer.
Cronin DP; Harlan LC; Potosky AL; Clegg LX; Stevens JL; Mooney MM
Am J Gastroenterol; 2006 Oct; 101(10):2308-18. PubMed ID: 17032196
[TBL] [Abstract][Full Text] [Related]
10. Management of Gastrointestinal Stromal Tumors.
Keung EZ; Raut CP
Surg Clin North Am; 2017 Apr; 97(2):437-452. PubMed ID: 28325196
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of 3-year vs 1-year adjuvant therapy with imatinib in patients with high risk of gastrointestinal stromal tumour recurrence in the Netherlands; a modelling study alongside the SSGXVIII/AIO trial.
Majer IM; Gelderblom H; van den Hout WB; Gray E; Verheggen BG
J Med Econ; 2013 Sep; 16(9):1106-19. PubMed ID: 23808902
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy observation on imatinib adjuvant therapy with longer duration in patients with gastrointestinal stromal at intermediate or high risk of recurrence].
Li J; Dang YZ; Gao J; Shen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):216-20. PubMed ID: 23536338
[TBL] [Abstract][Full Text] [Related]
13. The impact of additional malignancies in patients diagnosed with gastrointestinal stromal tumors.
Smith MJ; Smith HG; Mahar AL; Law C; Ko YJ
Int J Cancer; 2016 Oct; 139(8):1744-51. PubMed ID: 27299364
[TBL] [Abstract][Full Text] [Related]
14. Clinical presentation, management and outcomes of gastrointestinal stromal tumors.
Al-Thani H; El-Menyar A; Rasul KI; Al-Sulaiti M; El-Mabrok J; Hajaji K; Elgohary H; Tabeb A
Int J Surg; 2014 Oct; 12(10):1127-33. PubMed ID: 25152441
[TBL] [Abstract][Full Text] [Related]
15. [Gastrointestinal stromal tumors: clinicopathologic and survival evaluation in Rebagliati Hospital].
Manrique MN; Soriano C; Yábar A; Frisancho O; Palacios AM
Rev Gastroenterol Peru; 2012; 32(4):357-65. PubMed ID: 23307085
[TBL] [Abstract][Full Text] [Related]
16. Treatment patterns for stage III colon cancer and factors related to receipt of postoperative chemotherapy in Louisiana.
Wu X; Chen VW; Andrews PA; Chen L; Hsieh M; Fontham ET
J La State Med Soc; 2004; 156(5):255-61. PubMed ID: 15554095
[TBL] [Abstract][Full Text] [Related]
17. [Treatment progress of gastrointestinal stromal tumor].
Ji X; Ji JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):292-6. PubMed ID: 23536354
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal stromal tumors in Turkey: experiences from 3 centers.
Selcukbiricik F; Yalçın S; Tural D; Erdamar S; Demir G; Doğusoy G; Mandel NM
Onkologie; 2013; 36(1-2):18-24. PubMed ID: 23429327
[TBL] [Abstract][Full Text] [Related]
19. The accuracy of three predictive models in the evaluation of recurrence rates for gastrointestinal stromal tumors.
Racz JM; Brar SS; Cleghorn MC; Jimenez MC; Azin A; Atenafu EG; Jackson TD; Okrainec A; Quereshy FA
J Surg Oncol; 2015 Mar; 111(4):371-6. PubMed ID: 25501790
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of 3-years of adjuvant imatinib in gastrointestinal stromal tumors (GIST) in the United States.
Sanon M; Taylor DC; Parthan A; Coombs J; Paolantonio M; Sasane M
J Med Econ; 2013; 16(1):150-9. PubMed ID: 22762291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
